Skip to main content
Fig. 4 | BMC Pregnancy and Childbirth

Fig. 4

From: Soluble urokinase plasminogen activator receptor in vaginally collected amniotic fluid predicting fetal inflammatory response syndrome: a prospective cohort study

Fig. 4

Amniotic fluid suPAR levels in fetal inflammatory response syndrome. The median concentration of suPAR in the FIRS group and the non-FIRS group: median, 32.36 ng/mL, IQR, 17.27–84.16, vs. median, 20.46 ng/mL, IQR, 11.49–36.63, respectively (Wilcoxon, P = 0.01). suPAR, soluble urokinase plasminogen activator receptor; FIRS, fetal inflammatory response syndrome; IQR, interquartile range

Back to article page